Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
The companies and opportunities are there, he said
Kendall, J
Planning out the process and finding focus are crucial
SELECT-SWITCH Study Design Intro: 12-week, randomized, double blind, head-to-head (H2H), Phase 3b/4 study that evaluated the efficacy and safety of RINVOQ (upadacitinib) + MTX versus HUMIRA (adalimumab) + MTX in 491 adult patients with moderate to severe RA who demonstrated prior failure to one non-adalimumab TNF inhibitor
But not just that, to be able to show them how to present and brand themselves better so they become highly sought-after for endorsements and sponsorships well into their professional future
US$ 21.30
US$ 26.50
US$ 20.25
US$ 23.75
US$ 24.17
